1/ How can we model each tumor’s unique biology instead of relying on one-size-fits-all approaches? In our latest blog post, we highlight findings from the recent PNAS paper with GenBio AI Research Scientist @probablybots and Co-Founder and Chief Scientist @ericxing, showing how contextualized networks pave the way for an interactome module in AIDO.

2/ Traditional methods miss patient-specific details. Contextualized models infer sample-specific GRNs, unlocking a more precise understanding of tumor biology.

3/ Why this matters for AIDO: • Generating personalized models on-demand for every individual • Unified ML paradigm for multi-modal data integration • Information flow from molecular to cellular scale improves disease models Paper 🔗 pnas.org/doi/10.1073/pn…

4/ This work strengthens AIDO’s vision: multiscale foundation models for predicting, simulating, and programming biology across contexts, from molecules to phenotypes. Read more ↓ genbio.ai/aido-interacto…

@genbioai Tumor heterogeneity and genome plasticity remain two of the greatest challenges in oncology—constantly reshaping cancer’s behavior and resistance to treatment. No two tumors are ever truly alike; even within a single tumor, cells evolve diverse genetic and molecular profiles

@genbioai The rise of AI-driven digital organisms offers a revolutionary shift. By creating virtual counterparts of tumors that learn, adapt, and evolve from real patient data, researchers can simulate complex biological behavior with unprecedented precision. These digital organisms model

@genbioai Traditional cancer research has long relied on generalized models that often overlook the molecular individuality of each patient’s tumor. These one-size-fits-all approaches, while valuable for establishing broad principles, struggle to capture the complex, dynamic nature of

@genbioai Wow

@genbioai Wow

@genbioai Llevar a la marca a nuevas alturas.

@genbioai There was a time he needed to bail himself for over 10mil or so....not sure wat our contribution to that was! That must have landed him in unwanted debts

@genbioai Lol

@genbioai 9 comment lol

@genbioai Very interesting 🧐 molecular-cancer.biomedcentral.com/articles/10.11…

@genbioai The advancements are enormous!

@genbioai Gumarth